What is INSM's five-year median EV/Sales?

17.4x. Half of INSM's weekly readings over the last five years were higher and half were lower. This page has 390 weekly readings, from May 6, 2019 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares INSM only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Insmed Inc (INSM) valuation history

Health Care

$93.39

Latest weekly close · Market cap $20.3B

Within its usual range

As of Oct 24, 2026

INSM's EV/Sales of 17.3x is higher than 50% of its weekly readings over the last five years.

Weekly EV/Sales with its 5-year range

EV/Sales each weekMiddle half of the last 5 years5-year median 17.4×

5-year median: 17.4×
10-year median: 17.7×
5-year low to high: 8.2×–95.9×
Versus 5-year median: -1%

EV/Sales

50thpercentile

of its weekly readings over the last five years

Within its usual range

Growth, last 12 months vs the year before

Revenue: +186%accelerating
EPS: n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.

PriceRevenue, last 12 months100 = first reading

EV/Sales at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

INSM EV/Sales at each year-end
Year-end	EV/Sales	5-year percentile
Dec 29, 2025	81.4×	97
Dec 30, 2024	33.9×	92
Dec 25, 2023	17.1×	68
Dec 26, 2022	11.1×	8
Dec 27, 2021	16.7×	39
Dec 28, 2020	18.6×	60
Dec 30, 2019	19.0×	50

Health Care peers on EV/Sales

Each percentile compares a stock with its own last five years.

Compare INSM with peers

Health Care peers of INSM on EV/Sales
Stock	EV/Sales	Versus its own history	5-year percentile
ABBVAbbVie	8.7×	Historically high	100
AMGNAmgen	7.5×	Historically high	96
ARWRArrowhead Pharmaceuticals Inc	11.1×	Below its usual range	29
BBIOBridgebio Pharma Inc	21.5×	Below its usual range	24
BIIBBiogen	4.3×	Historically high	96

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on INSM

No articles about INSM yet. How valuation percentiles work

Loading peers and related research…

About this history

What is INSM's current EV/Sales?: INSM's EV/Sales of 17.3x is higher than 50% of its weekly readings over the last five years.
What is INSM's five-year median EV/Sales?: 17.4x. Half of INSM's weekly readings over the last five years were higher and half were lower. This page has 390 weekly readings, from May 6, 2019 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares INSM only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.